Cytokine and chemokine tear levels in patients with uveitis

被引:44
作者
Carreno, Ester [1 ,5 ]
Portero, Alejandro [1 ,6 ]
Herreras, Jose M. [1 ,2 ,3 ]
Garcia-Vazquez, Carmen [1 ]
Whitcup, Scott M. [4 ,7 ]
Stern, Michael E. [4 ]
Calonge, Margarita [1 ,3 ]
Enriquez-de-Salamanca, Amalia [1 ,3 ]
机构
[1] Univ Valladolid, IOBA Inst Appl OphthalmoBiol, Valladolid, Spain
[2] Univ Clin Hosp, Valladolid, Spain
[3] CIBER BBN Biomed Res Networking Ctr Bioengn Bioma, Valladolid, Spain
[4] Allergan Pharmaceut Inc, Irvine, CA USA
[5] NHS Fdn Trust, Bristol Eye Hosp, Bristol, Avon, England
[6] Hosp Zarzuela INCIVI, Immunol & Ocular Surface Unit, Madrid, Spain
[7] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA
关键词
chemokine; cytokine; tears; uveitis; ENDOTOXIN-INDUCED UVEITIS; INFLAMMATORY CYTOKINES; AQUEOUS-HUMOR; PROINFLAMMATORY CYTOKINES; MULTIPLE CYTOKINES; CATARACT-SURGERY; OCULAR SURFACE; EYE DISEASE; EXPRESSION; RECEPTOR;
D O I
10.1111/aos.13292
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposeTo determine whether the levels of cytokines and chemokines in tears differ in uveitis patients and healthy subjects. MethodsNinety-two uveitis patients (mean age 46.4years) and 157 control healthy subjects (mean age 49.5years) were recruited. Subjects with ocular surface diseases such as dry eye were excluded from the study. Using multiplex bead-based assays, tears (4l) were analysed for the concentration of interleukin (IL)-1, IL-1RA, IL-2, IL-6, IL-7, IL-8/CXCL8, IL-10, IL-12p70, IL-15, IL-17A, IL-23, epidermal growth factor (EGF), fractalkine/CX3CL1, interferon-, IP-10/CXCL10, monocyte chemo-attractant protein (MCP)-1/CCL2, tumour necrosis factor-, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-1, TGF-2 and TGF-3. Tear molecule levels were compared between the groups and among the different forms of uveitis and disease severity. ResultsEpidermal growth factor, IL-1RA, IL-7, IL-8/CXCL8, IP-10/CXCL10, MCP-1/CCL2, TGF-2 and VEGF were detected in more than 75% of the samples in both groups. Statistically significant differences in percentage of detection between control and patient groups were found for IL-23, IL-1, IL-15, EGF, fractalkine/CX3CL1 and MCP-1/CCL2. The concentrations of IL-1RA, IL-8/CXCL8, fractalkine/CX3CL1, IP-10/CXCL10, VEGF and TGF-2 in uveitis tear samples were elevated compared to controls (p<0.05). Significant differences in tear levels of those molecules and also EGF were also present depending on the anatomic classification of uveitis. ConclusionThere were significant differences in the levels of several cytokines and chemokines in tears of patients with uveitis compared with healthy subjects. These results can help understand the underlying pathophysiology of the uveitis and could potentially aid in diagnosis.
引用
收藏
页码:E405 / E414
页数:10
相关论文
共 61 条
[51]   Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments [J].
Sack, Robert ;
Conradi, Lenard ;
Beaton, Ann ;
Sathe, Sonal ;
McNamara, Nancy ;
Leonardi, Andrea .
EXPERIMENTAL EYE RESEARCH, 2007, 85 (04) :528-538
[52]   Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease [J].
Saetta, M ;
Mariani, M ;
Panina-Bordignon, P ;
Turato, G ;
Buonsanti, C ;
Baraldo, S ;
Bellettato, CM ;
Papi, A ;
Corbetta, L ;
Zuin, R ;
Sinigaglia, F ;
Fabbri, LM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (10) :1404-1409
[53]   Clinical Review: Anti-TNFα Therapies in Uveitis: Perspective on 5 Years of Clinical Experience [J].
Sharma, Srilakshmi M. ;
Nestel, Achim R. ;
Lee, Richard W. J. ;
Dick, Andrew D. .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2009, 17 (06) :403-414
[54]   Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis [J].
Sijssens, Karen M. ;
Rijkers, Ger T. ;
Rothova, Aniki ;
Stilma, Jan S. ;
Schellekens, Peter A. W. J. F. ;
de Boer, Joke H. .
EXPERIMENTAL EYE RESEARCH, 2007, 85 (04) :443-449
[55]   Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis [J].
Simonini, Gabriele ;
Taddio, Andrea ;
Cattalini, Marco ;
Caputo, Roberto ;
de Libero, Cinzia ;
Parentin, Fulvio ;
Pagnini, Ilaria ;
Lepore, Loredana ;
Cimaz, Rolando .
PEDIATRIC RHEUMATOLOGY, 2013, 11
[56]   Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial [J].
Suhler, Eric B. ;
Lowder, Careen Y. ;
Goldstein, Debra A. ;
Giles, Tracy ;
Lauer, Andreas K. ;
Kurz, Paul A. ;
Pasadhika, Sirichai ;
Lee, Shelly T. ;
de Saint Sardos, Alexandre ;
Butler, Nicholas J. ;
Tessler, Howard H. ;
Smith, Justine R. ;
Rosenbaum, James T. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (04) :481-486
[57]   Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome [J].
Teoh, S. C. B. ;
Sharma, S. ;
Hogan, A. ;
Lee, R. ;
Ramanan, A. V. ;
Dick, A. D. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (02) :263-264
[58]  
Trinh L, 2008, MOL VIS, V14, P2428
[59]   Laser flare photometry: A noninvasive, objective, and quantitative method to measure intraocular inflammation [J].
Tugal-Tutkun I. ;
Herbort C.P. .
International Ophthalmology, 2010, 30 (5) :453-464
[60]  
Valentincic NV, 2011, MOL VIS, V17, P2003